CANF logo

Can-Fite BioPharma (CANF) Cash From Operations

Annual CFO

-$8.44 M
+$2.36 M+21.86%

December 31, 2023

Summary

Performance

1-Year Change

+21.86%

3-Year Change

+30.03%

5-Year Change

-103.13%

15-Year Change

+5.93%

CANF Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

63.18%
CANF annual cash flow from operations is higher than 63.18% of companies in Healthcare sector

High & Low

All-time High

-$3.65 M

3-Year Low

-$10.80 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CANF previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 10, 2025
CANF next annual earnings announcement is scheduled for Feb 10, 2025

OtherCANFcash flowmetrics:

Annual CFI

$498.00 K
CANF annual cash flow from investing activities is $498.00 thousand

Annual CFF

$9.14 M
CANF annual cash flow from financing activities is $9.14 million

Annual FCF

-$8.44 M
CANF annual free cash flow is -$8.44 million

Annual CAPEX

$2000.00
CANF annual capital expenditures is $2000.00

Quarterly CFO

N/A

June 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

CANF Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$777.40 K
CANF quarterly cash flow from operations is currently at an all-time high

3-Year Low

-
CANF quarterly cash flow from operations 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
CANF previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

Feb 10, 2025
CANF next earnings announcement is scheduled for Feb 10, 2025

OtherCANFcash flowmetrics:

Quarterly CFI

-
CANF quarterly cash flow from investing activities value is unknown

Quarterly CFF

-
CANF quarterly cash flow from financing activities value is unknown

Quarterly FCF

-
CANF quarterly free cash flow value is unknown

Quarterly CAPEX

-
CANF quarterly capital expenditures value is unknown

TTM CFO

N/A

June 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

CANF TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$1.86 M
CANF TTM cash flow from operations is currently at an all-time high

3-Year Low

-
CANF TTM cash flow from operations 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
CANF previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

Feb 10, 2025
CANF next earnings announcement is scheduled for Feb 10, 2025

OtherCANFcash flowmetrics:

TTM CFI

-
CANF TTM cash flow from investing activities value is unknown

TTM CFF

-
CANF TTM cash flow from financing activities value is unknown

TTM FCF

-
CANF TTM free cash flow value is unknown

TTM CAPEX

-
CANF TTM capital expenditures value is unknown

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

CANF Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+21.9%--
3 y3 years+30.0%--
5 y5 years-103.1%--

CANF Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+21.9%
5 y5-yearat high+30.0%
alltimeall time-130.9%+30.0%

Can-Fite BioPharma Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2023
-$8.44 M(-21.9%)
-
-
Dec 2022
-$10.80 M(+9.6%)
-
-
Dec 2021
-$9.86 M(-18.3%)
-
-
Dec 2020
-$12.06 M(+8.8%)
-
-
Dec 2019
-$11.08 M(+166.8%)
-
-
Dec 2018
-$4.16 M(-53.7%)
-
-
Dec 2017
-$8.97 M(+3.0%)
-
-
Dec 2016
-$8.71 M(+87.3%)
-
-
Dec 2015
-$4.65 M(-36.5%)
-
-
Dec 2014
-$7.33 M(-15.1%)
-
-
Dec 2013
-$8.63 M
-$2.81 M(+66.6%)
-$8.63 M(+25.9%)
Sep 2013
-
-$1.69 M(+2.2%)
-$6.85 M(+15.3%)
DateAnnualQuarterlyTTM
Jun 2013
-
-$1.65 M(-33.8%)
-$5.95 M(+5.5%)
Mar 2013
-
-$2.49 M(+141.4%)
-$5.64 M(+29.7%)
Dec 2012
-$4.35 M(-20.9%)
-
-
Dec 2012
-
-$1.03 M(+32.7%)
-$4.35 M(-3.6%)
Sep 2012
-
-$777.40 K(-42.0%)
-$4.51 M(-0.9%)
Jun 2012
-
-$1.34 M(+11.6%)
-$4.55 M(-6.0%)
Mar 2012
-
-$1.20 M(+0.6%)
-$4.84 M(-12.0%)
Dec 2011
-$5.50 M(+50.4%)
-
-
Dec 2011
-
-$1.19 M(+46.0%)
-$5.50 M(+27.7%)
Sep 2011
-
-$817.00 K(-49.9%)
-$4.30 M(+23.4%)
Jun 2011
-
-$1.63 M(-12.3%)
-$3.49 M(+87.7%)
Mar 2011
-
-$1.86 M
-$1.86 M
Dec 2010
-$3.65 M
-
-

FAQ

  • What is Can-Fite BioPharma annual cash flow from operations?
  • What is the all time high annual CFO for Can-Fite BioPharma?
  • What is Can-Fite BioPharma annual CFO year-on-year change?
  • What is the all time high quarterly CFO for Can-Fite BioPharma?
  • What is the all time high TTM CFO for Can-Fite BioPharma?

What is Can-Fite BioPharma annual cash flow from operations?

The current annual CFO of CANF is -$8.44 M

What is the all time high annual CFO for Can-Fite BioPharma?

Can-Fite BioPharma all-time high annual cash flow from operations is -$3.65 M

What is Can-Fite BioPharma annual CFO year-on-year change?

Over the past year, CANF annual cash flow from operations has changed by +$2.36 M (+21.86%)

What is the all time high quarterly CFO for Can-Fite BioPharma?

Can-Fite BioPharma all-time high quarterly cash flow from operations is -$777.40 K

What is the all time high TTM CFO for Can-Fite BioPharma?

Can-Fite BioPharma all-time high TTM cash flow from operations is -$1.86 M